Malobabić Z, Pešić S. Receptura - priručnik iz farmakologije, Prosveta Niš, 2003.
Tasić S, Pešić S. Gljivične Infekcije - dijagnoza i mogućnosti terapije, Punta Niš,
Grbović L, Radenković, M, Pešić S. Neželjena i toksična dejstva antiherpetičkih lekova. U: Terzić B, Andjelković D, Meyboom R, Stanulović M, (Urednici). Farmakovigilanca i bezbedna primena lekova. 1.izdanje. Farmaceutski fakultet Beograd. (Beograd: BB Soft; ISBN 86-80263-34-6), 2006. p. 102-107.
Pešić S, Balkanov T. Farmakologija za stomatologe. Medicinski fakultet Niš, (Niš: Five & Co; ISBN 978-86-80599-62-5), 2007. p. 1-376.
Pešić S, Grbović L, Jovanović A, Radenković M. Acetylcholine-induced contractions in the porcine internal mammary artery: possible role of muscarinic receptors. J Vet Med A, Vol.46 (8): 509-515, 1999. IF/1999=0,600, M22
Pešić S, Jovanović A, Grbović L, Inić M, Munjaš N. Endothelium-dependent relaxation in perforating branch of human internal mammary artery. Cardiovasc Surg Vol. 8 (5): 393-399, 2000. IF/2000=0,862, M22
Pešić S, Jovanović A, Grbović L. Muscarinic receptors subtype mediating vasorelaxation of perforating branch of human internal mammary artery. Pharmacology. Vol. 63 (3): 185-190, 2001. IF/2001=1,563, M22
Grbović L, Radenković M, Prostran M, Pešić S. Characterization of adenosine action in isolated rat renal artery: Possible role of adenosine A2A receptors. Gen Pharmacol. Vol. 35 (1): 29-36, 2001. IF/2001=0,778, M23
Pešić S, Grbović L, Jovanović A. Acetylcholine induces contractions in the perforating branch the human internal mammary artery: Protective role of the vascular endothelium. Pharmacology. Vol. 64 (4): 182-188, 2002. IF/2002=1,599, M22
Stojić D, Radenković M, Kršljak E, Popović J, Pešić S, Grbović L. Influence of the endothelium on the vasorelaxant response to acetylcholine and vasoactive intestinal polypeptide in the isolated rabbit facial artery. Eur J Oral Sci. Vol.111 (2):137-143, 2003.
IF/2003=1,248, M22
Pešić S, Grbović L, Jovanović A, Radenković M, Stojić D, Cvetković Z, Ilić I. Endothelium-dependent relaxation of canine uterine artery in response to acetylcholine: the possible involvement of alternative pathways. J Vet Med A Physiol Pathol Clin Med. Vol. 50 (8): 391-396, 2003. IF/2003=0,558, M23
Pešić S, Grbović L, Jovanović A, Radenković M, Stojić D. Effect of the vascular endothelium on contractions induced by noradrenaline and phenylephrine in perforating branch of the human internal mammary artery. Pol J Pharmacol. Vol. 55 (4): 581-593, 2003. IF/2003=0,823, M23
Pešić S, Grbović L, Radenković M, Stojić D, Nikolić V, Cvetković Z. The relaxant effect of vasoactive intestinal polypeptide in the isolated canine uterine artery: the role of endothelium. J Vet Med A Physiol Pathol Clin Med. Vol. 51 (9-10): 394-399, 2004.
IF/2004=0,471, M23
Radenković M, Grbović L, Pešić S, Stojić D. Isolated rat inferior mesenteric artery response to adenosine: possible participation of Na+/K+-ATPase and potassium channels. Pharmacol Rep. Vol. 57 (6): 824-382, 2005. IF/2005=1,029, M23
Stojić D, Pešić S, Radenković M, Popović-Roganović J, Pešić Z, Grbović L. Responses of the human submandibular artery to ACh and VIP. J Dent Res. Vol. 86 (6): 565-570, 2007. IF/2007 = 3.496, M21
Grbović L, Djokić J, Radenković M, Pešić S. Analysis of the vasorelaxant action of angiotensin II in the isolated rat renal artery. J Pharmacol Sci. Vol. 106 (3): 376-384, 2008. IF/2008 = 2.599, M22
Pešić S, Grbović L, Stoiljković M, Nikolić V, Djokić J. Functional characterization of the muscarinic receptors involved in endothelium-dependent relaxation in isolated canine uterine artery. J Vet Pharmacol Therap. Vol. 32 (2), 109-115, 2009. IF/2009 = 1.408, M21
Tasić S, Miladinović-Tasić N, Djordjević J, Pešić S, Avramović M. Ten-year prevalence of fungal peritonitis in the city of Nis, South Serbia. Cent Eur J Med. Vol. 5 (1): 49-52, 2010.
Nikolic VN, Jankovic SM, Velickovic-Radovanović R, Apostolović S, Stanojevic D, Zivanovic S, Stefanovic N, Pesic S, Jevtovic-Stoimenov T, Djuric J, Markovic V, Milovanovic JR. Population pharmacokinetics of carvedilol in patients with congestive heart failure. J Pharm Sci. 2013; 102(8): 2851-2858. IF 3.130, M21
Nikolic VN, Jevtovic-Stoimenov T, Stokanovic D, Milovanovic M, Velickovic-Radovanović R, Pesic S, Stoiljkovic M, Pesic G, Ilic S, Deljanin-Ilic M, Marinkovic D, Stefanovic N, Jankovic SM. An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure. J Cardiology 2013;61:37-43; IF:2.298, M22
Nikolic VN, Jevtovic-Stoimenov T, Velickovic-Radovanović R, Ilic S, Deljanin-Ilic M, Marinkovic D, Apostolović S, Stanojevic D, Zivanovic S, Stefanovic N, Pesic S, Ruzic-Zecevic D, Milovanovic JR, Jankovic SM. Population pharmacokinetics of bisoprolol in patients with chronic heart failure Eur J Clin Pharmacol 2013; 69: 859-865. IF=2.741, M22
Milovanovic M, Pesic G, Nikolic V, Jevtovic-Stoimenov T, Vasic K, Jovic Z, Deljanin-Ilic M, Pesic S. Vitamin D deficiency is associated with increased IL-17 and TNFα levels in patients with chronic heart failure. Arq Bras Cardiol. 2012 Mar;98(3):259-65.
SCIE, IF/2009 = 0,224, M23
Veselinović Jovana B, Toropov Andrey A, Toropova Alla P, Nikolić Goran M, Veselinović Aleksandar M. Monte Carlo Method-Based QSAR Modeling of Penicillins Binding to Human Serum Proteins. Archiv der Pharmazie 2015; 348:1-6. IF: 1.396 (M22)
Damnjanovic I, Najman S, Stojanovic S, Stojanovic D, Veljkovic A, Kocic H, Langerholc T5, Damnjanovic Z, Pesic S. Crosstalk between possible cytostatic and antiinfl amatory potential of ketoprofen in the treatment of culture of colon and cervix cancer cell lines. Bratisl Lek Listy 2015; 116 (4) 227 – 232 (M23).
Damnjanovic I, Kocic G, Najman S, Stojanovic S, Ilic B, Veljkovic A, Pesic S, Smelcerovic A. POSSIBLE MOLECULAR MECHANISMS AND PATHWAYS INVOLVED IN BH3 MIMETIC ACTIVITY OF ALPHA-LIPOIC ACID ON HUMAN COLON CANCER CELL LINE. FARMACIA, 2019, Vol. 67, 2: 226-34.
Pešić S, Grbović L, Radenković M. Disfunkcija endotela: Mehanizmi nastanka i terapijske mogućnosti. Med Pregl. Vol. 59 (7-8): 335-341, 2006. M51
Pešić S, Pešić G, Mančev Z, Malobabić ZS. Diuretic effect of icv administered N-carboxymethyl-Phe-Leu in rats. Arch Toxicol Kinet Xenobiot Metab. Vol. 2: 571-572, 1994. M53
Pešić S, Malobabić ZS. Antinociceptivno dejstvo N-carboxymethyl-Phe-Leu u Hot-Plate testu na pacovima. Arhiv za Farmaciju. Vol. 44 (1-2): 44-45, 1994. M52
Pešić S, Pešić G, Mančev Z, Malobabić ZS. Uticaj N-carboxymethyl-Phe-Leu na telesnu temperaturu pacova. Acta Medica Medianae. Vol. 33 (4): 5-10, 1994. M52
Pešić S, Pešić G, Mančev Z, Malobabić ZS. Uticaj inhibitora neutralne endopeptidaze (3. 4. 24. 11) N-carboxymethyl-Phe-Leu na diurezu kod pacova. Acta Medica Medianae. Vol. 33 (5): 5-10, 1994. M52
Pešić S, Malobabić ZS. Antinociceptivno dejstvo inhibitora neutralne endopeptidaze N-carboxymethyl-Phe-Leu u pacova. Acta Medica Medianae. Vol. 33 (6): 11-16, 1994. M52
Pešić S, Cvetković Z. Uloga endogenih neuroaktivnih supstancija u regulaciji telesne temperature. Veterinarski Glasnik Vol. 48: 825-828, 1994. M52
Pešić S, Malobabić ZS. Effect of neutral endopeptidase inhibitor N-carboxymethyl-Phe-Leu on the pain threshold of rats. Iugoslav Physiol Pharmacol Acta. Vol. 31: 165-171, 1995. M53
Pešić G, Radulović J, Mančev Z, Pešić S, Malobabić ZS. Uticaj inhibitora enkefalin-degradirajućih enzima na humoralni i celularni imuni odgovor pacova. Acta Medica Medianae. Vol. 35 (1): 5-12, 1996. M52
Pešić S, Pešić G, Mančev Z, Malobabić ZS. Uticaj met-enkefalina na visceralni bol kod pacova. Acta Medica Medianae. Vol. 35 (2): 5-12, 1996. M52
Pešić S, Pešić G, Mančev Z, Malobabić ZS. Analgesic effect of opioid peptides against visceral pain in rats can be potentates by neutral endopeptidase inhibitor. Iugoslav. Physiol. Pharmacol. Acta. Vol. 32: 189-195, 1996. M53
Pešić S, Jovanović A, Inić M, Munjaš N, Grbović L. Endothelium dependent relaxation in response to acetylcholine in the human internal mammary artery. Iugoslav. Physiol. Pharmacol. Acta. Vol. 32: 291-295, 1996. M53
Pešić S, Jovanović A, Grbović L. Kontraktilno dejstvo acetilholina na perforantnoj grani humane interne mamilarne arterije: Moguća uloga muskarinskih M3 receptora. Acta Fac. Med. Naiss. Vol. 17 (1): 17-24, 2000. M53
Pešić S, Mitić R. Farmakoterapijske mogućnosti upotrebe antagonista serotoninskih receptora u terapiji povraćanja. Acta Medica Medianae. Vol. 39 (4): 45-54, 2000. M52
Pešić S, Grbović L, Radenković M. Neželjena i toksična dejstva antivirusnih lekova. Acta Infectologica Yugoslavica. Vol. 6 (1): 183-188, 2001. M53
Grbović L, Pešić S, Radenković M. Klinička farmakologija antivirusnih lekova. Acta Infectologica Yugoslavica. Vol.6 (1): 123-132, 2001. M53
Radenković M, Grbović L, Pešić S. Rezistencija prema antivirusnim lekovima. Acta Infectologica Yugoslavica. Vol. 6 (1): 189-193, 2001. M53
Pešić S, Grbović L, Jovanović A, Radenković, M. Kontraktilno dejstvo noradrenalina na perforantnu granu humane interne mamilarne arterije; Moguća modulatorna uloga vaskularnog endotela. Acta Medica Medianae. Vol. 41 (7): 43-52, 2002. M52
Pešić S, Grbović L, Radenković M, Stojić D, Nikolić V. Predominant role for NO in the acetylcholine-induced relaxation of canine uterine artery. Acta biologica iugoslavica - serija C: Physiologica et pharmacologica acta Vol. 40 (1-3): 29-35, 2004. M53
Pešić S, Stefanović M, Nikolić V. Mogućnosti farmakološke terapije abnormalnih materičnih krvarenja. Acta Medica Medianae. Vol. 45 (3): 43-52, 2006. M52
Stoiljković M, Pešić S, Stojiljković N. Topografsko ispitivanje pontomedularnih respiratorno-senzitivnih jedara mozga pacova mikrostimulacijama glutamatom. Acta Medica Medianae. Vol. 47 (1): 41-46, 2008. M52
Pešić S, Grbović L, Nikolić V. Primena antimikrobnih lekova u terapiji infekcija u ginekologiji i akušerstvu. Acta Medica Medianae. Vol. 47 (3): 56-64, 2008. M52
Pesic S¹, Jovanovic H, Trajkovic H. CURRENT KNOWLEDGE ABOUT THE ETIOPATHOGENESIS AND THERAPY OPTIONS FOR COVID-19. Health Care 49(3), 2020; 43-53. M53 UDK NUMBERS: 616.98:578.834 DOI: https://doi.org/10.5937/zdravzast49-28409
Krtinić D, Živadinović R, Živadinović B, Jović Z, Pešić S, Pavlović V, Pavlović S, Trandafilović M, Stokanović D, Nedin-Ranković G, Cvetanović A, Todorovska I, Živković N, Golubović M. Local therapy with imiquimod as a possible medical treatment of vulvar intraepithelial neoplasms. Acta medica Medianae: In press. DOI: 10.5633/amm.2019.0101. M51
Pešic S. Bad bugs need new drugs. 6th Annual spring Scientific Symposium in Anestesiology and intensive care. Proceeding Scientific symposium 188-189. 2014.
Pešic S. Antibiotic use optimization in critically ill patients in the light of pharmacokinetics changes. 7th Annual spring Scientific Symposium in Anestesiology and intensive care. Proceeding Scientific symposium 191-192. 2015
.
Pešic S. New strategies in the treatment of clostridium difficile induced colitis. 8th Annual spring Scientific Symposium in Anestesiology and intensive care. Proceeding Scientific symposium 207-208. 2017
Damnjanovic I, Kocic G, Njaman S, Stojanovic S, Veljkovic A, Pesic S. NF-kB Potential Chemopreventive target of Meloxicam in the treatment of colon cancer cell in vitro. VI Kongres Farmaceuta Srbije sa medjunarodnim ucescem. p: 257. 2014 (ISBN: 978-86-918145-0-2)
Damnjanović Ivana, Stojanović Dušica, Kocić Gordana, Najman Stevo, Stojanović Sanja, Pešić Srđan.The role of alpha –lipoic acid in cancer prevention and treatment. 52nd Days of preventive medicine, September 25th-28th, 2018, Niš, Serbia, Abstract book: 146.
Damnjanović I, Kocić Gordana, Najman Stevo, Stojanović Sanja, Veljković Andrej, Pešić Srđan. The role and significance of mitochondrial markers of apoptosis in colon cancer treatment. Archives of pharmacy, special issue (Abstracts from VII Serbian congress of pharmacy with inernacional participations, October 10th-14th, 2018, Belgrade, Serbia.) 2018, 2(68): 294.
Srđan Z. Pešić, Dane A. Krtinić. Možemo li uvek i dovoljno sniziti holesterol? PCSK9 inhibitori u fokusu. Can we always lower cholesterol levels enough? PCSK9 inhibitors in focus. XI NEDELJA BOLNIČKE
KLINIČKE FARMAKOLOGIJE 2019. ZBORNIK SAŽETAKA. Predavanje po pozivu. 2019; 20-21.
Krtinić D, Pešić S, Stokanović D, Nedin-Ranković G, Jovanović H, Trajković H, Petković M, Ristić L, Vučić M, Conić I, Dimitrijević A, Popović A, Todorovska-Rašić M, Bjelaković M, Skakić A, Živadinović A, Živadinović J. Komparativna analiza primene oksikodona i fiksne kombinacije oksikodon/nalokson kod onkoloških pacijenata. Zbornik sažetaka XII Nedelja bolničke kliničke farmakologije Beograd 2020: 80-81
Trajković H, Pešić S, Nikolić V, Stokanović D, Nedin-Ranković G, Krtinić D, Jovanović H, Petković M, Vučić M, Conić I, Dimitrijević A, Todorovska-Rašić M, Bjelaković M, Živadinović A, Živadinović J, Kostić E, Živadinović B. Značaj simptomatske terapije za suzbijanje neželjenih efekata antidolorozne terapije kod onkoloških pacijenata. Zbornik sažetaka XII Nedelja bolničke kliničke farmakologije Beograd 2020: 82-83
Jovanović H, Pešić S, Nikolić V, Stokanović D, Nedin-Ranković G, Krtinić D, Trajković H, Stojiljković N, Ilić S, Petković M, Ristić L, Vučić M, Conić I, Todorovska-Rašić M, Živadinović A, Živadinović J, Stošić S, Ivanković N, Rančić Lj. Značaj adherence onkoloških pacijenata u farmakoterapiji hroničnog bola maligne etiologije. Zbornik sažetaka XII Nedelja bolničke kliničke farmakologije Beograd 2020: 84-85
Pešić S, Krtinić D. Biološki lek: biosimilar – mogućnost i problem. Predavanje po pozivu. Zbornik sažetaka XII Nedelja bolničke kliničke farmakologije Beograd 2020: 44-45